Suven Pharmaceuticals Ltd - 543064 - Board Meeting Outcome for With Reference To The Above Subject, The Board Of Directors Of The Company, At Its Meeting Held Today I.E. February 08, 2022, Approved The Following Along With Other Business Matters.
1. Took on record and approved the attached Un-Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and nine months ended 31st December, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Reports of the Statutory Auditors. 2. Dividend a) The Board has declared an interim Dividend of Rs.1.00 per equity share (100% of Face value of Rs.1.00 each) and one-time special dividend of Rs. 2.00 per equity share (200% of Face value of Rs.1.00), totaling to Rs. 3.00 per equity share (300% of Face value of Rs. 3.00 each) for the financial year 2021-22. b) The Board has approved the Record Date i.e., 16th February, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be paid on and from 22nd February 2022.08-02-2022